Panjon Limited

PANJON

INE744D01019

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:57 2024-07-04 EDT			5-day change	1st Jan Change
21.28 ^INR	+9.97%		+13.55%	+21.05%

05-27	Panjon Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
05-27	Panjon Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Panjon Limited announced that it has received INR 9.613245 million in funding

February 01, 2024

On February 2, 2024, Panjon Limited closed the transaction.

Latest news about Panjon Limited

Panjon Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-27	CI
Panjon Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-27	CI
Panjon Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Panjon Limited announced that it has received INR 9.613245 million in funding	02-01	CI
Panjon Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-08	CI
Panjon Limited Announces Appointment of Athak Mahajan and Rajiv Kumar as Additional Director (Non-Executive Independent Director)	23-08-31	CI
Panjon Limited announced that it expects to receive INR 9.613245 million in funding	23-08-30	CI
Panjon Limited Announces Resignation of Directors	23-08-29	CI
Panjon Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-12	CI
Panjon Limited Announces Board Changes	23-08-12	CI
Panjon Limited Announces Resignation of Shubham Sharma as Company Secretary	23-06-08	CI
Panjon Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-25	CI
Panjon Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-25	CI
Panjon Limited Announces Resignation of Sonamasati as Company Secretary and Compliance Officer	23-02-14	CI
Panjon Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Panjon Limited Appoints Shubham Sharma as Company Secretary and Compliance Officer	23-02-11	CI
Panjon Limited Announces Resignation of Sonam Asati as Company Secretary	23-01-14	CI
Panjon Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-09-16	CI
Panjon Limited Appoints Sonam Asatia as Company Secretary and Compliance Officer, with Effect from August 8, 2022	22-08-08	CI
Panjon Limited Announces Resignation of Anjali Shukla as Non-Executive-Non Independent Director	22-08-08	CI
Panjon Limited Announces Resignation of Khushbu Vohra as Company Secretary	22-06-04	CI
Panjon Limited Reports Unaudited Standalone and Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015	16-02-12	CI
Panjon Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2015	15-11-10	CI
Panjon Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015	15-08-31	CI
Panjon Limited Reports Unaudited Standalone Earnings Results for Second Quarter and Six Months Ended September 30, 2014	14-11-14	CI

Panjon Limited is an India-based company that is engaged in the manufacturing and trading of consumer and pharmaceutical products. The Company is primarily engaged in manufacturing and trading of allopathic and ayurvedic medicines. The Company specializes in medicinal, digestive, ayurvedic and confectionary products. The Company's brands include Panjon and Swad. The Company's products include PANJON Tablet, PANJON Balm, PANJON Inhaler, PANJON cough drops, Swad Digestive Drops, Swad Chatpati Digestive Drops, Percy Masala Candy, KERY Cough Drops, PANJON Dental Care Cream and others. The Company's subsidiary company is Raunaq Laboratories Ltd.

Sector

Pharmaceuticals

Calendar

2024-08-05 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PANJON LIMITED	+21.05%	3.78M
ELI LILLY AND COMPANY	+54.07%	809B
NOVO NORDISK A/S	+39.16%	621B
JOHNSON & JOHNSON	-7.05%	351B
MERCK & CO., INC.	+15.44%	319B
ABBVIE INC.	+5.72%	289B
ASTRAZENECA PLC	+14.28%	238B
ROCHE HOLDING AG	-0.61%	221B
NOVARTIS AG	+14.62%	218B
AMGEN INC.	+7.42%	166B